The effect of the dextro isomer of propranolol on sinus rate and cardiac arrhythmias

Powell, 1958, Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol, J. Pharmacol. & Exper. Therap., 122, 480 Black, 1962, Pharmacology of a new adrenergic beta-receptor blocking compound (Nethalide), Lancet, 2, 311, 10.1016/S0140-6736(62)90103-4 Black, 1964, A new adrenergic beta-receptor antagonist, Lancet, 1, 1080, 10.1016/S0140-6736(64)91275-9 Lish, 1965, Pharmacological and toxicological properties of two new β-adrenergic receptor antagonists, J. Pharmacol. & Exper. Therap., 149, 161 1967, Acta pharmacol. (Kbh.), 25 Barrett, A. M., Crowther, A. F., Dunlop, D., Smith, L. H., and Shanks, R. G.: Cardio-selective beta blockade. Naunyn-Schmiedeberg's Arch. exper. Path. & Pharmakol. In press. Grandjean, 1966, Effects hémodynamiques des inhibiteurs des récepteurs adrénergiques-bêta pendant le cathétérisme cardiaque; comparaison entre le propranolol (“Inderal”) et la substance CIBA 39089-BA, Cardiologia (Basel), 49, 139, 10.1159/000168910 Levy, 1966, Inotropic and chronotropic effects of a series of β-adrenergic blocking drugs: some structure-activity relationships, 122, 373 Howe, 1963, Structure activity relationships of some β-adrenergic blocking agents, Biochem. & Pharmacol., 12, 85 Howe, 1966, Optical isomers of propranolol, Nature (Lond.), 210, 1336, 10.1038/2101336a0 Levy, 1967, Relation between β-adrenergic blocking potency and cardiotoxicity in a series of β-adrenergic receptor blocking drugs, Am. J. Cardiol., 19, 139, 10.1016/0002-9149(67)90333-5 Whitsitt, 1967, The cardiac beta-adrenergic receptor blocking actions of propranolol and its stereoisomers, Life Sci., 6, 939, 10.1016/0024-3205(67)90080-X Levy, 1965, Inotropic and metabolic effects of three beta-adrenergic receptor blocking drugs on isolated rabbit left atria, J. Pharmacol. & Exper. Therap., 150, 361 McInerny, 1965, Comparison of effects of propranolol and other cardiac adrenergic blocking agents on inotropic and chronotropic actions of catecholamines, 24, 712 Turner, 1966, Propranolol in the treatment of digitalis-induced and digitalis-resistant tachycardias, Am. J. Cardiol., 18, 450, 10.1016/0002-9149(66)90069-5 Wolfson, 1966, Treatment of cardiac arrhythmias with beta-adrenergic blocking agents. Clinical and experimental studies, Am. Heart J., 72, 177, 10.1016/0002-8703(66)90441-8 Black, 1965, Comparison of some properties of pronethalol and propranolol, Brit. J. Pharmacol., 25, 577 Rowlands, 1965, Propranolol (Inderal) in disturbances of cardiac rhythm, Brit. M. J., 1, 891, 10.1136/bmj.1.5439.891 Morales-Aguilerá, 1965, The effects on cardiac muscle of beta-receptor antagonists in relation to their activity as local anaesthetics, Brit. J. Pharmacol., 24, 332 Benfey, 1966, Anti-sympathomimetic and antifibrillatory effects of pronethalol and propranolol, Brit. J. Pharmacol., 26, 3 Vaughan Williams, 1966, Mode of action of beta receptor antagonists on cardiac muscle, Am. J. Cardiol., 18, 399, 10.1016/0002-9149(66)90062-2 Parmley, 1967, Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol and quinidine, J. Pharmacol. & Exper. Therap., 158, 11 Shanks, R. G.: Unpublished observation, 1967. Howitt, 1966, The role of beta-adrenergic blocking agents in cardiac therapy, 136 Lucchesi, 1965, The effects of pronethalol and its dextro-isomer upon experimental cardiac arrhythmias, J. Pharmacol. & Exper. Therap., 148, 94 Lucchesi, 1967, Anti-arrhythmic effects of beta adrenergic blocking agents, Ann. New York Acad. Sc., 139, 940, 10.1111/j.1749-6632.1967.tb41262.x Barrett, A. M., and Cullum, V. A.: In preparation.